BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fan F, Podar K. The Role of AP-1 Transcription Factors in Plasma Cell Biology and Multiple Myeloma Pathophysiology. Cancers (Basel) 2021;13:2326. [PMID: 34066181 DOI: 10.3390/cancers13102326] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Uckun FM, Qazi S. ERBB1/EGFR and JAK3 Tyrosine Kinases as Potential Therapeutic Targets in High-Risk Multiple Myeloma. Onco (Basel) 2022;2:282-304. [PMID: 36311273 DOI: 10.3390/onco2040016] [Reference Citation Analysis]
2 Bhosale PB, Kim HH, Abusaliya A, Vetrivel P, Ha SE, Park MY, Lee HJ, Kim GS. Structural and Functional Properties of Activator Protein-1 in Cancer and Inflammation. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-8. [DOI: 10.1155/2022/9797929] [Reference Citation Analysis]
3 Allegra A, Casciaro M, Barone P, Musolino C, Gangemi S. Epigenetic Crosstalk between Malignant Plasma Cells and the Tumour Microenvironment in Multiple Myeloma. Cancers (Basel) 2022;14:2597. [PMID: 35681577 DOI: 10.3390/cancers14112597] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Cotoraci C, Ciceu A, Sasu A, Miutescu E, Hermenean A. Bioactive Compounds from Herbal Medicine Targeting Multiple Myeloma. Applied Sciences 2021;11:4451. [DOI: 10.3390/app11104451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]